Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)
Status:
Completed
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy, safety, tolerability and
pharmacokinetics of multiple oral administration of MT-3995 in patients with NASH.